Since 2000, small-group health insurance premiums averaged annual increases of 5.5% nationally; however, double-digit increases were not uncommon, according to a report from the Urban Institute.
Since 2000, small-group health insurance premiums averaged annual increases of 5.5% nationally; however, double-digit increases were not uncommon for states and large metropolitan areas, according to a study from the Urban Institute.
As insurers and state Marketplaces gear up for the open enrollment period for 2015, concerns have surfaced about large premium increases among nongroup and small-group insurance, according to authors Linda J. Blumberg and John Holahan, both fellows with the Urban Institute’s Health Policy Center.
State departments are currently reviewing submitted premiums rates and have yet to make public the final approved rates for small-group and nongroup Marketplace plans.
In reviewing data from the Medical Expenditure Panel Survey—Insurance Component, the authors determined that over the past 13 years average premiums frequently increased by double-digit percentages in the small-group insurance market. These large increases were “often followed by significantly smaller increases (and sometimes even decreases)” the next year, according to Blumberg and Holahan.
Although Nebraska and Illinois both reported low average annual growth of just 4.6% and 4.2%, respectively, from 2000 to 2013, both states experienced double-digit annual increases in roughly half the years studied.
In the Tampa-St. Petersburg-Clearwater, Florida, metropolitan area during 2002 to 2013, small-group single premiums for employers with fewer than 50 workers reported a minimum annual growth of -33.9% and a maximum annual group of 28.8%. Plus, a third of the years during the 2002 to 2013 time period recorded double digit increases.
Employer- and individual-specific premium variation is expected to be reduced significantly in plans compliant with the Affordable Care Act (ACA), according to the authors. However, they added that 2014 through 2017 will be transitional years while individuals and employers acquaint themselves with the law, its provisions, and the coverage options provided.
“The ACA’s market reforms, which prohibit insurers in the small-group and nongroup insurance markets from varying premiums based upon health status or claims experience of the enrollees, should decrease year-to-year premium variation relative to the pre-reform period,” Blumberg and Holahan wrote. “This will become especially evident once past the early implementation years in which the insurers are calculating the contours of the new playing field and consumer decisions reach equilibrium.”
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
2 Commerce Drive
Cranbury, NJ 08512